(Q38050965)

27 August 2017

title

Safety and efficacy of dexmedetomidine in children with heart failure (English)

1 reference

27 August 2017

0 references

1 reference

Francis Lam

1

1 reference

27 August 2017

Chase Ransom

2

1 reference

27 August 2017

Jeffrey M Gossett

3

1 reference

27 August 2017

Aaron Kelkhoff

4

1 reference

27 August 2017

Paul M Seib

5

1 reference

27 August 2017

Michael L Schmitz

6

1 reference

27 August 2017

Janet C Bryant

7

1 reference

27 August 2017

Elizabeth A Frazier

8

1 reference

27 August 2017

Punkaj Gupta

9

1 reference

27 August 2017

publication date

9 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

34

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

835-841

1 reference

Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Dexmedetomidine and cardiac protection for non-cardiac surgery: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Endogenous nitric oxide and soluble tumor necrosis factor receptor levels are enhanced in infants with congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Use of dexmedetomidine in children after cardiac and thoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Heart failure in children: part I: history, etiology, and pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Effects of dexmedetomidine on coronary hemodynamics and myocardial oxygen balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

The use of dexmedetomidine in pediatric cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Alpha-2 agonists to reduce vasopressor requirements in septic shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Beneficial effects of dexmedetomidine on ischaemic myocardium of anaesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Ventilatory, hemodynamic and sedative effects of the α2 adrenergic agonist, dexmedetomidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-012-0546-7

Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock.

21 January 2018

1 reference

12 December 2020

Direct coronary and cerebral vascular responses to dexmedetomidine. Significance of endogenous nitric oxide synthesis

1 reference

12 December 2020

Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine.

1 reference

12 December 2020

Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate

1 reference

12 December 2020

Hemodynamic effects of dexmedetomidine in critically ill neonates and infants with heart disease

1 reference

12 December 2020

Use of dexmedetomidine in the pediatric intensive care unit

1 reference

12 December 2020

Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes

1 reference

12 December 2020

10.1007/S00246-012-0546-7

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1035607549

0 references

1 reference